查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1880579

猫疫苗市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测（2024-2032）

Feline Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 请询问到货日

价格

猫疫苗市场成长因素

由于宠物主人数量的增加和兽医护理水准的提高，全球猫疫苗市场持续稳定成长。根据最新的行业分析，在人们对猫健康意识的提高、传染病流行以及兽医诊所在预防保健中作用的不断增强等因素的推动下，到2024年，市场规模将达到15.8亿美元。受宠物饲养量增长和人畜共患病防治力度加大的推动，预计到2025年，市场规模将进一步增长至16.7亿美元。疫苗技术的进步和兽药生产商投资的增加预计将推动市场规模在2032年达到26.5亿美元。

市场推动因素：猫饲养率上升和疾病发生率上升

市场成长的主要推动因素是全球猫数量的显着成长。随着越来越多的家庭将猫作为伴侣动物饲养，对疫苗的需求也增加。例如，根据美国宠物用品协会（APPA）的一项调查，到2023-2024年，美国将有约4,900万户家庭养猫。高宠物拥有率直接推动了对核心疫苗的需求，例如狂犬病疫苗、猫白血病病毒疫苗 (FeLV) 和猫泛白血球减少症、病毒性呼吸道感染、猫白血病和猫疥疮疫苗 (FVRCP)。

此外，传染病的蔓延进一步推动了市场扩张。义大利南部的一项调查发现，在接受检测的 328 家猫中，73.5% 的猫猫泛白血球减少症病毒检测呈阳性，凸显了全球及时接种疫苗的迫切需求。随着疾病发病率的上升，宠物主人越来越重视透过可靠的疫苗接种计划来保护他们心爱的猫咪。

市场阻碍因素：发展中地区进入有限

儘管已开发市场有所成长，但新兴地区兽医服务可近性有限仍然是一个重大限制。兽医数量少、疫苗接种基础设施薄弱的国家在实施常规猫疫苗接种方面面临挑战。例如，肯亚只有 410 名兽医，这使得大规模疫苗接种计画难以实施。这最终限制了低收入地区的成长潜力。

市场机会：政府主导的猫疫苗接种计划

世界各国政府和地方政府正在扩大针对家猫和流浪猫的疫苗接种计划，从而创造了强劲的市场机会。在印度，纳西克市政公司将于 2025 年 7 月启动流浪猫狂犬病疫苗接种计划，这反映了以公共卫生为主导的疫苗接种运动的更广泛趋势。这些努力正在显着提高整个地区的疫苗接种率，并支持市场成长，预计到 2032 年市场规模将达到 26.5 亿美元。

市场挑战：宠物主人对疫苗的犹豫

对疫苗的犹豫，主要是由于对疫苗安全性和副作用的担忧，这仍然是市场扩张的一大挑战。根据美国兽医协会 (AVMA) 2024 年报告，许多宠物主人仍不愿给宠物接种疫苗，导致疫苗接种率存在差异，并减缓了整体市场接受度。

市场趋势：疫苗平台的进步

影响产业发展的关键趋势是创新疫苗平台的快速发展，例如重组疫苗和下一代疫苗。默克扩展了 NOBIVAC NXT 平台，其中包括将于 2024 年推出的 NOBIVAC NXT FeLV，凸显了在更广泛的保护、更持久的免疫力和更高的安全性方面取得的进展。预计持续的创新将推动2025年至2032年间强劲的需求成长。

区域洞察

北美 - 主要区域市场（2024年：6.7亿美元）

北美将占最大的市场占有率，达到42.40%，市场规模在2024年将达到6.7亿美元。强大的兽医基础设施、较高的可支配收入以及庞大的宠物数量支撑着该地区的领先地位。美国凭藉先进的兽医指南和完善的疫苗分销网络，继续保持其领先地位。

欧洲

由于宠物数量的增长、猫科疾病病例的增加以及政府支持的疫苗接种计划，预计欧洲将实现强劲增长。光是英国在2024年就将拥有1,080万隻宠物猫，这将推动疫苗需求。

亚太地区

亚太地区预计将呈现最高的复合年增长率，这主要得益于猫咪饲养率的上升和人们对猫科疾病认识的提高。预计到2024年，澳洲将拥有490万隻宠物猫，这将显着促进该地区的成长。

拉丁美洲、中东和非洲

由于政府主导的流浪猫疫苗接种计划的扩大以及人们对人畜共患病风险认识的提高，预计这些地区将保持稳定增长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场推动因素
  • 市场阻碍因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 主要国家和地区猫科疾病概览（2024 年）
  • 主要国家及地区监理现况（2024 年）
  • 猫科疾病疫苗接种概览
  • 主要公司新技术应用
  • 主要产业趋势（併购、合作等）

第五章：全球猫疫苗市场分析、洞察与预测（2019-2032）

  • 市场分析、洞察与预测 - 依技术分类
    • 灭活​​疫苗
    • 减毒活疫苗
    • 重组疫苗
    • 其他
  • 市场分析、洞察与预测 - 依疾病类型分类
    • 猫咪病毒性鼻气管炎
    • 狂犬病
    • 猫白血病病毒
    • 其他
  • 市场分析、洞察与预测 - 依给药途径分类
    • 肠外给药
    • 鼻腔给药
  • 市场分析、洞察与预测 - 依销售管道分类
    • 兽医院
    • 动物诊所
    • 药局药局
    • 其他
  • 市场分析、洞察与预测 - 依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美猫疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲猫疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 德国
    • 美国王国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区猫疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲猫疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

章节10：中东和非洲猫科动物疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 全球市占率分析（2024）
  • 公司简介
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Merck &Co., Inc.
  • Zoetis Services LLC
  • Ceva
  • Bioveta, a.s.
Product Code: FBI113898

Growth Factors of feline vaccines Market

The global feline vaccines market continues to expand steadily as pet ownership rises and veterinary healthcare becomes more advanced. According to the latest industry analysis, the feline vaccines market size reached USD 1.58 billion in 2024, driven by strong awareness of feline health, growing prevalence of infectious diseases, and the increased role of veterinary clinics and hospitals in preventive healthcare. The market is projected to grow further to USD 1.67 billion in 2025, influenced by expanding pet adoption and growing initiatives to prevent zoonotic diseases. By 2032, the market is expected to reach USD 2.65 billion, due to advancements in vaccine technology and increasing investment by veterinary pharmaceutical companies.

Market Drivers: Rising Cat Ownership and Growing Disease Prevalence

The primary driver supporting market growth is the significant rise in cat ownership worldwide. With households increasingly adopting cats as companion animals, the need for preventive vaccination continues to escalate. In the U.S., for example, around 49 million households owned a cat in 2023-2024, according to the American Pet Products Association. This high ownership level directly fuels the demand for core vaccines such as rabies, FeLV, FVRCP, and others.

Additionally, the prevalence of infectious diseases further strengthens market expansion. A study conducted in southern Italy showed that 73.5% of 328 domestic cats tested positive for feline panleukopenia virus, highlighting the global need for timely vaccination. With such increasing disease incidence, pet owners are more focused on safeguarding their animals through reliable vaccination programs.

Market Restraints: Limited Access in Developing Regions

Despite growth in developed markets, limited access to veterinary care in emerging regions remains a significant restraint. Countries with fewer veterinary professionals and limited vaccination infrastructure face challenges in adopting routine immunization for felines. For instance, Kenya has only 410 veterinarians, making widespread vaccination programs difficult to implement. This ultimately restricts growth potential in low-income regions.

Market Opportunities: Government Initiatives for Feline Immunization

Governments and municipal bodies across countries are increasingly adopting programs to vaccinate domestic and stray cats, creating strong market opportunities. In India, the Nashik Municipal Corporation launched a program in July 2025 to vaccinate stray cats against rabies, reflecting a broader trend of public-health-driven vaccination campaigns. Such initiatives contribute significantly to rising vaccine uptake across regions and are expected to support market value growth toward USD 2.65 billion by 2032.

Market Challenges: Vaccine Hesitancy Among Pet Owners

Vaccine hesitancy, largely driven by concerns about vaccine safety and side effects, continues to challenge market expansion. The American Veterinary Medical Association (AVMA) reported in 2024 that many pet owners remain hesitant about immunization, which creates gaps in vaccine coverage and slows overall market adoption.

Market Trends: Advancements in Vaccine Platforms

A major trend shaping the industry is the rapid development of innovative vaccine platforms such as recombinant and next-generation vaccines. Merck's expansion of the NOBIVAC NXT platform, including NOBIVAC NXT FeLV launched in 2024, highlights growing advancements focused on broader protection, longer immunity, and improved safety profiles. This continuous innovation is expected to drive strong demand between 2025 and 2032.

Regional Insights

North America - Leading Regional Market (USD 0.67 Billion in 2024)

North America accounted for the largest market share of 42.40% in 2024, with a market value of USD 0.67 billion. Strong veterinary healthcare infrastructure, high disposable income, and a large pet population underpin regional leadership. The U.S. remains the dominant country, supported by advanced veterinary guidelines and a robust vaccine distribution network.

Europe

Europe is set for strong growth due to increasing pet population, rising cases of feline diseases, and government-supported vaccination programs. The U.K. alone had 10.8 million pet cats in 2024, boosting vaccine demand.

Asia Pacific

Asia Pacific is projected to exhibit the fastest CAGR, driven by rising cat ownership and growing awareness of feline diseases. Australia reported 4.9 million pet cats in 2024, contributing heavily to regional growth.

Latin America & Middle East & Africa

These regions will experience steady growth due to increasing government-run stray cat vaccination programs and rising awareness of zoonotic risks.

Competitive Landscape

The market is semi-consolidated, with top players including Zoetis Services LLC, Merck & Co., Inc., Elanco, Virbac, Boehringer Ingelheim, Ceva, and Bioveta. These companies invest heavily in R&D, new vaccine platforms, and expanded manufacturing capabilities to sustain market leadership.

Segmentation By Technology

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Disease Type

  • Feline Viral Rhinotracheitis
  • Rabies
  • Feline Leukemia Virus
  • Others

By Route of Administration

  • Parenteral
  • Intranasal

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.S.
    • Canada
  • Europe (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Feline Diseases by Key Countries, By Key Countries/ Region, 2024
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2024
  • 4.3. Overview of Vaccination for Feline Diseases
  • 4.4. New Technology Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Technology
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Type
    • 5.2.1. Feline Viral Rhinotracheitis
    • 5.2.2. Rabies
    • 5.2.3. Feline Leukemia Virus
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Parenteral
    • 5.3.2. Intranasal
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Type
    • 6.2.1. Feline Viral Rhinotracheitis
    • 6.2.2. Rabies
    • 6.2.3. Feline Leukemia Virus
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Parenteral
    • 6.3.2. Intranasal
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Type
    • 7.2.1. Feline Viral Rhinotracheitis
    • 7.2.2. Rabies
    • 7.2.3. Feline Leukemia Virus
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Parenteral
    • 7.3.2. Intranasal
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Type
    • 8.2.1. Feline Viral Rhinotracheitis
    • 8.2.2. Rabies
    • 8.2.3. Feline Leukemia Virus
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Parenteral
    • 8.3.2. Intranasal
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Type
    • 9.2.1. Feline Viral Rhinotracheitis
    • 9.2.2. Rabies
    • 9.2.3. Feline Leukemia Virus
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Parenteral
    • 9.3.2. Intranasal
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Feline Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Type
    • 10.2.1. Feline Viral Rhinotracheitis
    • 10.2.2. Rabies
    • 10.2.3. Feline Leukemia Virus
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Parenteral
    • 10.3.2. Intranasal
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles (Overview, Technology, SWOT analysis, Recent developments, strategies, financials (based on availability)
    • 11.2.1. Elanco
    • 11.2.2. Boehringer Ingelheim International GmbH
    • 11.2.3. Virbac
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Zoetis Services LLC
    • 11.2.6. Ceva
    • 11.2.7. Bioveta, a.s.

List of Tables

  • Table 1: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 2: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 3: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 4: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 5: Global Feline Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 6: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 7: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 8: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 9: North America Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 10: North America Feline Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 11: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 12: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 13: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 14: Europe Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 15: Europe Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 16: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 17: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 18: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 19: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 20: Asia Pacific Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 22: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 23: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 24: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 25: Latin America Feline Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 26: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 27: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 28: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 29: Middle East & Africa Feline Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

List of Figures

  • Figure 1: Global Feline Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Feline Vaccines Market Value Share (%), by Technology, 2024 & 2032
  • Figure 3: Global Feline Vaccines Market Value Share (%), by Disease Type, 2024 & 2032
  • Figure 4: Global Feline Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032
  • Figure 5: Global Feline Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032
  • Figure 6: Global Feline Vaccines Market Value Share (%), by Region, 2024 & 2032
  • Figure 7: North America Feline Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 8: North America Feline Vaccines Market Value Share (%), by Technology, 2024
  • Figure 9: North America Feline Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 10: North America Feline Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 11: North America Feline Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 12: North America Feline Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 13: North America Feline Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 14: North America Feline Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 15: North America Feline Vaccines Market Value (USD billion), By Country, 2024 & 2032
  • Figure 16: North America Feline Vaccines Market Value Share (%), By Country, 2024
  • Figure 17: Europe Feline Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 18: Europe Feline Vaccines Market Value Share (%), by Technology, 2024
  • Figure 19: Europe Feline Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 20: Europe Feline Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 21: Europe Feline Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 22: Europe Feline Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 23: Europe Feline Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 24: Europe Feline Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 25: Europe Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 26: Europe Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 27: Asia Pacific Feline Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 28: Asia Pacific Feline Vaccines Market Value Share (%), by Technology, 2024
  • Figure 29: Asia Pacific Feline Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 30: Asia Pacific Feline Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 31: Asia Pacific Feline Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 32: Asia Pacific Feline Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 33: Asia Pacific Feline Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 34: Asia Pacific Feline Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 35: Asia Pacific Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 36: Asia Pacific Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 37: Latin America Feline Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 38: Latin America Feline Vaccines Market Value Share (%), by Technology, 2024
  • Figure 39: Latin America Feline Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 40: Latin America Feline Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 41: Latin America Feline Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 42: Latin America Feline Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 43: Latin America Feline Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 44: Latin America Feline Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 45: Latin America Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 46: Latin America Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 47: Middle East & Africa Feline Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 48: Middle East & Africa Feline Vaccines Market Value Share (%), by Technology, 2024
  • Figure 49: Middle East & Africa Feline Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 50: Middle East & Africa Feline Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 51: Middle East & Africa Feline Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 52: Middle East & Africa Feline Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 53: Middle East & Africa Feline Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 54: Middle East & Africa Feline Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 55: Middle East & Africa Feline Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 56: Middle East & Africa Feline Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 57: Global Feline Vaccines Market Share (%), By Company, 2024